Dr. Jagan

Dr. Jagan

Visiting Consultant 

26 Years of Experience

Cardiologist

MBBS, MD, DM

Reg. No.:62140, Tamil Nadu Medical Council

Rela Hospital, Chennai

English, Hindi

Consultation Fee ₹ 300

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Jagan

Expert Help When You Need It – Plan in 60 Minutes

About Dr. Jagan

  • Dr. Jagan is a well-known cardiologist with 26 years of experience.
  • He specializes in artificial pacemaker surgery, defibrillation, heart valve surgery, thrombolytic treatment, coronary angioplasty, stent implantation, artificial pacemaker surgery, and treatment of ventricular septal defect (VSD).
  • He received his MBBS from The Tamil Nadu Dr. M.G.R. Medical University in 1998 and his DM in cardiology in 2016.
  • Dr. Jagan also earned his MD in general medicine from The Tamil Nadu Dr. Michael R. Medical University in 2004.
  • He has published his research articles in well-known national journals, including the Indian Journal of Public Health Research and Development.
  • He is also frequently requested to speak about cardiac surgeries as a guest speaker at scientific gatherings, CMEs, and international conferences.
  • Dr. Jagan holds membership in the Cardiological Society of India (CSI), the Indian Association of Clinical Cardiologists and the Association of Physicians of India (API).

Confirm Your Consultation With Dr. Jagan

Expert Help When You Need It – Plan in 60 Minutes

Education

  • MBBS, The Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU), 1998
  • MD in General Medicine, The Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU), 2004
  • DM in Cardiology, The Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU), 2016

OPD Schedule Of Dr. Jagan

Book Appointment

Past Experience

  • Cardiologist, Balaji Medical College, 2018
  • Vivek, K., & Jagan, G. (2019). Platelet-Rich Plasma Injections for Chronic Plantar Fasciitis. Indian Journal of Public Health Research and Development, 10(11), 1399.
  • Manivel, T., & Jagan, G. (2019). To Evaluate the Efficacy of Metformin Monotherapy in Newly Diagnosed Type 2 Diabetes Mellitus Patients by Assessing the HBA1C Percentage Reduction as a Single Diagnostic Tool for Glycemic Control and its Incidence in Preventing Macrovascular Complications: A Prospective Open Label Study for a Period of 6 Months Duration. Indian Journal of Public Health Research and Development, 10(11), 1467.
  • Ramakrishnan, C., Jagan, G., & Vedamanickam, R. (2019). Study on Carcinomas of Breast with Special Reference to Expressions of Vascular Endothelial Growth Factor (VEGF). Indian Journal of Public Health Research and Development, 10(11), 4037.
  • Cardiological Society of India (CSI)
  • Tamil Nadu Medical Council
  • Indian Association of Clinical Cardiologists
  • The Association of Physicians of India (API)